Form 8-K - Current report:
SEC Accession No. 0001558370-25-011134
Filing Date
2025-08-12
Accepted
2025-08-12 06:10:42
Documents
13
Period of Report
2025-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amph-20250808x8k.htm   iXBRL 8-K 59499
2 EX-99.1 amph-20250808xex99d1.htm EX-99.1 16637
  Complete submission text file 0001558370-25-011134.txt   195366

Data Files

Seq Description Document Type Size
3 EX-101.SCH amph-20250808.xsd EX-101.SCH 3690
4 EX-101.LAB amph-20250808_lab.xml EX-101.LAB 15361
5 EX-101.PRE amph-20250808_pre.xml EX-101.PRE 10385
15 EXTRACTED XBRL INSTANCE DOCUMENT amph-20250808x8k_htm.xml XML 4635
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)